FindTrial
Sign In

Clinical Study on the Clinical Characteristics and Prognostic Factors of Newly Diagnosed Hepatocellular Carcinoma Patients

Clinical Study on the Clinical Characteristics and Prognostic Factors of Newly Diagnosed Hepatocellular Carcinoma Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118004
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic carcinoma

Interventions

Case group:None

Sponsors

Fifth Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age over 18 years old, regardless of gender; 2. Patients newly diagnosed with liver cancer in our hospital from January 31, 2019 to December 31, 2024; 3. Have complete baseline data and at least one follow-up record in our hospital.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with carcinoma in situ; 2. Patients who have not received treatment within 120 days after diagnosis; 3. Lost to follow-up before the first treatment, or follow-up time<30 days (unless death occurs within this period); 4. Patients with missing relevant information;

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Progression-free survival;—

Countries

China

Contacts

Public ContactXi Liu

Fifth Affiliated Hospital, Sun Yat-Sen University

liuxi26@mail.sysu.edu.cn+86 756 2528527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026